HANetf ICAV Indxx Healthcare Innovation UCITS ETF Acc (WELP)
10.45p (1.91%) Previous:
|Index:||The Indxx Global NextGen Healthcare Index is designed to measure the performance of companies involved in the NextGen Healthcare sector, as defined by Indxx.|
The Fund seeks to track the price and yield performance, before fees and expenses, of...
Read full aim for HANetf ICAV
|Ongoing Charge (OCF/TER):||0.59%|
In certain cases, where no TER or OCF is shown, additional costs may apply. Please ensure you have read the Key Investor Information Document, Factsheet, Prospectus and any other relevant documentation prior to investing.
|IRHYTHM TECHNOLOGIES INC||1.52%|
|INTRA-CELLULAR THERAPIES INC||1.43%|
|IONIS PHARMACEUTICALS INC||1.41%|
|ACADIA PHARMACEUTICALS INC||1.39%|
|NEXTGEN HEALTHCARE INC||1.38%|
|NEUROCRINE BIOSCIENCES INC||1.38%|
|REGENERON PHARMACEUTICALS INC||1.35%|
Recently viewed shares
Recently viewed investments
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.